José Cotter

BACKGROUND: A recent meta-analysis has suggested that proton pump inhibitor (PPI) therapy is associated with lower clinical remission rates and a higher number of hospitalizat...

Tiago Curdia Gonçalves ;

Pedro Boal Carvalho ;

Maria João Moreira ;

Vítor Macedo Silva ;

José Cotter ;

Tiago Lima Capela ;

Francisca Dias de Castro ;

Marta Freitas ;

12/15/2021

Deep Ulcers in Acute Ulcerative Colitis at Index Endoscopy Predict Corticosteroid Resistance

Gastroenterology Department, Hospital da Senhora da Oliveira, Guimarães, Portugal.

Vítor Macedo Silva ;

Tiago Curdia Gonçalves ;

Maria João Moreira ;

José Cotter ;

Francisca Dias de Castro ;

Joao Carlos Goncalves ;

Cátia Arieira ;

Joana Magalhães ;

Claudia Macedo ;

01/11/2024

Perianal Involvement in Crohn`s Disease: Are There Always Two Sides to Every Coin?

BACKGROUND: Crohn's disease (CD) is complicated with perianal disease in 21-23% of patients. Presence of perianal disease has been associated with a disabling course of CD and dreadful im...

Sofia Xavier ;

José Cotter ;

Francisca Dias de Castro ;

Maria João Moreira ;

Rui Maglhaes ;

12/13/2019

P051 Identifying High-Risk Patients With Acute Severe Ulcerative Colitis: Is the ACE Index Useful?

BACKGROUND: Treatment delay in patients admitted with acute severe ulcerative colitis (ASUC) are associated with increased mortality. Therefore, it is essential to identify on...

Joao Moreira Maria ;

Vítor Macedo Silva ;

Tiago Lima Capela ;

Marta Freitas ;

Tiago Curdia Gonçalves ;

José Cotter ;

Francisca Dias de Castro ;

Cátia Arieira ;

12/15/2021

Upper Gastrointestinal (GI) Morbidity, Peptic Ulcer Risk, and Proton Pump Inhibitor (PPI)/H2 Blocker (H2B) Use in Patients Treated with Bruton‚Äôs Tyrosine Kinase Inhibitors (BTKis) During Routine Care

Introduction:Novel oncolytic agents, including the first-in-class BTKi ibrutinib, have transformed CLL/SLL and MCL treatment. Later-approved BTKis have offered additional treatment choice...

Sofia Xavier ;

Maria João Moreira ;

José Cotter ;

Francisca Dias de Castro ;

Rui Magalhaes ;

11/04/2022

Subcutaneous Versus Intravenous Infliximab Therapy: Toward Higher Drug Concentrations

Gastroenterology Department, Hospital da Senhora da Oliveira, Guimarães, Portugal, Guimarães, Portugal.

Ana Isabel Ferreira ;

José Cotter ;

Cátia Arieira ;

Sofia Xavier ;